I just read an article about a study showing Taxotere improving survival rates over Adriamycin. I had posted a few weeks back that my medical oncologist switched my chemo regimen not just from Adriamycin, but also from Taxol to Taxotere based on another study's results. Well, I feel better knowing this now and also it demonstrates the Cancer Institute's desire to be at the forefront of new cancer treatments.
Article here: http://www.caring4cancer.com/go/cancer/news?NewsItemId=20071213elin033.xml
No comments:
Post a Comment